Early serum uric acid decline and 30-day survival after out-of-hospital cardiac arrest - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Early Changes in Serum Uric Acid and 30-Day Outcomes Following Out-of-Hospital Cardiac Arrest

  • By

  • Tomoyoshi Tamura

  • Ryo Yamamoto

  • Koichiro Homma

  • Nobuya Kitamura

  • Tomohisa Nomura

  • Takashi Tagami

  • Yasuo Yasunaga

  • Shotaro Aso

  • Munekazu Takeda

  • Junichi Sasaki

  • November 20, 2026

Share

Objective:

To assess whether serum uric acid (UA) change during the first 24 hours after out-of-hospital cardiac arrest (OHCA) is associated with 30-day survival and neurological outcome.

Approach:
  • Design and population: Prospective, multicenter observational study of 375 patients in the SOS-KANTO 2017 cohort with UA measured at hospital arrival and 24 hours after cardiac arrest.
  • Exposure and outcomes: UA decline was calculated as the percentage decrease from arrival to 24 hours. Outcomes were 30-day survival and good neurological status (Cerebral Performance Category 1 or 2).
  • Analysis: Associations were assessed using adjusted models accounting for patient, arrest, and institutional factors; additional analyses considered renal comorbidity and temperature control.
Key Findings:
  • Of 375 patients, 209 survived to 30 days and 166 did not.
  • Median admission UA was similar in survivors and non-survivors, while median UA decline was greater among survivors: 21% versus 2.5% (p<0.001).
  • Each 10-percentage-point greater UA decline was associated with higher odds of 30-day survival (adjusted OR 1.10; 95% CI 1.00–1.20; p=0.048).
  • The association with survival persisted in an analysis accounting for temperature control and pre-arrest renal comorbidity (adjusted OR 1.09; 95% CI 1.01–1.19; p=0.04).
  • Greater UA decline was also associated with good neurological outcome (adjusted OR 1.19 per 10-percentage-point increase; 95% CI 1.05–1.35; p=0.006).
Interpretation:

The authors report that early serum UA decline was associated with 30-day survival and good neurological outcome. The study does not establish that this association is independent of renal dysfunction or identify the physiological processes underlying the UA trajectory.

Limitations:
  • Serial renal-function measurements and urine-output data were unavailable, limiting assessment of renal dysfunction’s contribution.
  • Requiring UA measurements at both time points excluded patients without a 24-hour measurement, including some who died early; the direction and extent of resulting selection bias are unknown.
  • Detailed causes of death were unavailable, preventing attribution of the association to specific mechanisms.
  • UA decline and lactate clearance were measured over different intervals, so their prognostic performance could not be directly compared.
Conclusion:

Early UA decline was associated with short-term survival and favorable neurological outcomes after OHCA. The authors call for prospective validation alongside renal, metabolic, hemodynamic, and neurological measures.

Sources:

Original Source(s)

Related Content